RT Journal Article
SR Electronic
T1 The ventral striatum harbours patient specific intracranial neural signatures of obsessions and compulsions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.04.21254830
DO 10.1101/2021.04.04.21254830
A1 Fridgeirsson, Egill A
A1 Bais, MN
A1 Eijsker, N
A1 Thomas, RM
A1 Smit, DJA
A1 Bergfeld, IO
A1 Schuurman, PR
A1 van den Munckhof, P
A1 de Koning, P
A1 Vulink, N
A1 Figee, M
A1 Mazaheri, A
A1 van Wingen, GA
A1 Denys, D
YR 2021
UL http://medrxiv.org/content/early/2021/04/06/2021.04.04.21254830.abstract
AB Deep brain stimulation is a treatment option for patients with refractory obsessive-compulsive disorder. A new generation of stimulators hold promise for closed loop stimulation, with adaptive stimulation in response to biological signals Here we aimed to discover a suitable biomarker in the ventral striatum in patients with obsessive compulsive disorder using local field potentials. We induced obsessions and compulsions and trained a deep learning model on the recorded time series. Average classification sensitivities were 47% for obsessions and 66% for compulsions for patient specific models at 25% chance level. Sensitivity for obsessions reached over 90% in one patient, whereas performance was near chance level when the model was trained across patients. Optimal sensitivity for obsessions and compulsions was obtained at different recording sites. This study shows that closed loop stimulation is a viable option for OCD, but that intracranial biomarkers for obsessive-compulsive disorder are patient and not disorder specific.Competing Interest StatementThe deep brain stimulation devices were provided by Medtronic for research purposes. The company had no role in the design of the study, data analysis, drafting of the manuscript, or manuscript submission.Clinical TrialNL7486Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been reviewed and approved by the Institutional Review Board of the Academic Medical Center Amsterdam.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon reasonable request.